COSMOS PharmaceuticalCOSMOS Pharmaceutical Corporation3349東証プライム小売業FY ending May 2026, consolidated, J-GAAP

COSMOS Pharmaceutical FY ending May 2026 results

COSMOS Pharmaceutical brought in ¥1.1T in revenue.

Out of every ¥100 of sales, about ¥4 is left as operating profit.

Revenue changed +8.7% from the prior year, operating profit +4.8%.

Revenue and profit pattern

Revenue and profit upRevenue grew faster

Revenue +8.7% · profit +4.8%, calculated from disclosed figures.

Operating leverage: 0.55× (profit growth ÷ revenue growth)

FY ending May 2025 → FY ending May 2026

Revenue for the FY ending May 2026 was ¥1.1T, up +8.7% from ¥1.01T a year earlier.
Operating income grew +4.8% to ¥42.4B and net income grew +3.4% to ¥32B, so profit rose more slowly than sales.
Operating cash flow increased +12.1% to ¥58.8B, but capital expenditure of ¥70.5B for new stores pushed free cash flow to -¥11.7B.

Many new store openings and the everyday-low-price policy lifted sales, with groceries growing the most
The company held back on passing inflation through to prices to stay cheaper than rivals, which trimmed its gross margin slightly
Higher costs from inflation and a larger store count pushed SG&A up

If hiring, including pharmacists and registered sellers, cannot keep up with store growth, openings may slow and service may suffer
Large stores need review under Japan's Large-Scale Retail Store Location Act, and delays in finding sites or approvals could push back opening plans
Earthquakes, typhoons, or other disasters that damage stores or supply networks could hurt results

Annual Securities Report (44th term) / 経営者による財政状態、経営成績及びキャッシュ・フローの状況の分析 · Annual Securities Report (44th term) / 事業等のリスク

FY ending May 2025 → FY ending May 2026

For every ¥100 COSMOS Pharmaceutical sells, how much goes where, and how much is kept.

FY ending May 2026

Gross margin20.9%

Operating margin3.9%

Net margin2.9%

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Show source documents (6)

EDINET (FSA Japan)
有価証券報告書－第44期(2025/06/01－2026/05/31)
ID S100YYDI2026-08-26Open
EDINET (FSA Japan)
有価証券報告書－第43期(2024/06/01－2025/05/31)
ID S100WLSP2025-08-28Open
EDINET (FSA Japan)
有価証券報告書－第42期(2023/06/01－2024/05/31)
ID S100UAMF2024-08-29Open
EDINET (FSA Japan)
有価証券報告書－第41期(2022/06/01－2023/05/31)
ID S100RS022023-08-30Open
EDINET (FSA Japan)
有価証券報告書－第40期(令和3年6月1日－令和4年5月31日)
ID S100P3732022-08-30Open
EDINET (FSA Japan)
有価証券報告書－第39期(令和2年6月1日－令和3年5月31日)
ID S100MD0R2021-08-30Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.